Skip to content

Rampart Bioscience vs ViaNautis

Rampart Bioscience logo

Rampart Bioscience

Leading a new era of effective, safe and accessible gene medicines

28 employees · est. 2019 · Monrovia, United States

VS
ViaNautis logo

ViaNautis

Targeted Nanomedicines

42 employees · est. 2018 · Cambridge, United Kingdom

ViaNautis is the older company (2019 vs 2018).

Side-by-Side Comparison

Rampart Bioscience ViaNautis
Founded
2019 2018 older
Headquarters
Monrovia, United States Cambridge, United Kingdom
Employees
28 42
Industry
Biopharma, Biotechnology, Health and Wellness Biopharma, Biotechnology
Funding Stage
Series A Series A
Total Funding
$125.00M $22.10M
Funding Rounds
2 3
Services
Development of Novel DNA-Based Medicines, Research in Gene Delivery and Protein Sciences, Non-Viral DNA Delivery Systems Development of genetic therapeutics, Non-viral delivery systems, Collaboration with pharmaceutical companies, Proprietary platform technology
Target Customers
Patients with Genetically Driven Diseases, Healthcare Providers Seeking Advanced Therapies Pharmaceutical companies, Biotechnology firms, Healthcare providers, Patients with genetic disorders
Taxonomy
Gene MedicinesGenetically Driven DiseasesGene DeliveryProtein SciencesClinical TranslationNon-viral DNA Delivery +9 Targeted NanomedicinesCell And Gene TherapyPolyNaut® NanovesiclesNon-Viral Delivery SystemBlood-Brain BarrierScalable Manufacturing +9
Website
rampartbio.com vianautis.com
Rampart Bioscience logo

About Rampart Bioscience

Rampart Bioscience, founded in 2019, is pioneering advancements in the Biopharma and Biotechnology industries. Based in the United States, the company aims to lead a new era of effective, safe, and accessible gene medicines, targeting patients with genetically driven diseases. Its innovative approac...

ViaNautis logo

About ViaNautis

ViaNautis, founded in 2018 and headquartered in the United Kingdom, is innovating within the Biopharma and Biotechnology industries. With the slogan "Targeted Nanomedicines", the company is advancing cell and gene therapy through its proprietary polyNaut® nanovesicles, a non-viral delivery system th...

Also comparing in this category

Comparing more than these two?

Get Rampart Bioscience, ViaNautis and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Rampart Bioscience compare?

A PDF of Rampart Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Rampart Bioscience was founded in 2019, based in Monrovia, United States, with 28 employees. Rampart Bioscience, founded in 2019, is pioneering advancements in the Biopharma and Biotechnology industries. Based in the United States, the company aims to lead a new era of effective, safe, and ac. ViaNautis was founded in 2018, based in Cambridge, United Kingdom, with 42 employees. ViaNautis, founded in 2018 and headquartered in the United Kingdom, is innovating within the Biopharma and Biotechnology industries. With the slogan "Targeted Nanomedicines", the company is advancing.
Rampart Bioscience has raised $125.00M and ViaNautis $22.10M. Latest stage: Rampart Bioscience Series A, ViaNautis Series A.
Both work in Biopharma and Biotechnology.

Compare Rampart Bioscience with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Rampart Bioscience on 11 Mar 2026, and ViaNautis on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout